Results 151 to 160 of about 29,949 (204)

Enoxaparin Dosing and Target anti-Factor Xa Achievement in Infants by Postmenstrual Age. [PDF]

J Pediatr Pharmacol Ther
Perez D, Mathew K.
europepmc   +1 more source

Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis. [PDF]

Res Pract Thromb Haemost
Ageno W, Arcelus JI, Stroh C, Djoudi Y, Abdel-Moneim M, Khan I, Ponomareva E, Carrier M.   +7 more
europepmc   +1 more source

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin. [PDF]

Cancers (Basel)
Baghdadi MA, do Carmo Las Casas PHF, Mbemba E, Rousseau A, Kempaiah P, Svistunov AA, Bitsadze V, Sabbah M, Fareed J, Van Dreden P, Trachana V, Lefkou E, Gerotziafas G.   +12 more
europepmc   +1 more source

Sharp recanalization of extensive multilevel central venous occlusions in a young patient with familial Mediterranean fever: A case report. [PDF]

Radiol Case Rep
Turkistani F, Aldeen WS, Algain AH, Khankan A.   +3 more
europepmc   +1 more source

Long-term enoxaparin use and osteoporosis risk: a real-world cohort study with integrative computational and network toxicology approaches. [PDF]

J Transl Med
Liu ZJ, Li XM, Liu F, Zhang ZM, Wang CL.
europepmc   +1 more source

Thromboinflammatory and Pharmacological Effects of Low-Molecular-Weight Heparins in Acute Venous Thromboembolism: An Integrated Clinical and In Silico Analysis. [PDF]

Med Sci (Basel)
Onar LC, Guner E, Dalkiran IO, Yilmaz I.
europepmc   +1 more source

Enoxaparin [PDF]

Reactions Weekly, 2021
The development of low-molecular and ultra-low-molecular weight heparins has changed anticoagulation treatment options. Enoxaparin is a low-molecular weight heparin (LMWH), which works on Factor Xa and is indicated for both the prevention and treatment ...
Padayachee, N., Schoeman, N., Schellack, Natalie   +2 more
core   +3 more sources